Position in QNCX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,314,245
-$533,620 QoQ
Shares Held
72,251
+71435.6% QoQ
Ownership
7.10%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1
of 25 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Derivatives in QNCX
reported options exposure · as of Sep 30, 2021CallValue
$13,024,886
CallShares
710
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. QNCX ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in QNCX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,314,245 | 72,251 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,669,641 | 91,789 | Shares | Sole | 2026-08-14 | |
| 2021-09-30 | $1,847,865 | 20,160 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $13,024,886 | 142,100 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $1,088,249 | 20,533 | Shares | Sole | 2021-08-18 | |
| 2020-12-31 | $361,140 | 13,000 | Shares | Sole | 2021-02-12 | |
| 2020-12-31 | $777,840 | 28,000 | Call | Sole | 2021-02-12 | |
| 2020-12-31 | $4,722,600 | 170,000 | Put | Sole | 2021-02-12 | |
| 2020-09-30 | $150,000 | 3,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $2,000,000 | 40,000 | Shares | Sole | 2020-11-16 | |
| 2020-09-30 | $150,000 | 3,000 | Put | Sole | 2020-11-16 | |
| 2020-03-31 | $1,140,250 | 25,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||